1. Home
  2. RCUS vs WEAV Comparison

RCUS vs WEAV Comparison

Compare RCUS & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • WEAV
  • Stock Information
  • Founded
  • RCUS 2015
  • WEAV 2011
  • Country
  • RCUS United States
  • WEAV United States
  • Employees
  • RCUS N/A
  • WEAV N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • WEAV EDP Services
  • Sector
  • RCUS Health Care
  • WEAV Technology
  • Exchange
  • RCUS Nasdaq
  • WEAV Nasdaq
  • Market Cap
  • RCUS 727.1M
  • WEAV 837.7M
  • IPO Year
  • RCUS 2018
  • WEAV 2021
  • Fundamental
  • Price
  • RCUS $8.28
  • WEAV $10.44
  • Analyst Decision
  • RCUS Buy
  • WEAV Strong Buy
  • Analyst Count
  • RCUS 11
  • WEAV 5
  • Target Price
  • RCUS $25.33
  • WEAV $16.10
  • AVG Volume (30 Days)
  • RCUS 1.2M
  • WEAV 670.2K
  • Earning Date
  • RCUS 05-06-2025
  • WEAV 05-05-2025
  • Dividend Yield
  • RCUS N/A
  • WEAV N/A
  • EPS Growth
  • RCUS N/A
  • WEAV N/A
  • EPS
  • RCUS N/A
  • WEAV N/A
  • Revenue
  • RCUS $141,000,000.00
  • WEAV $212,950,000.00
  • Revenue This Year
  • RCUS N/A
  • WEAV $17.08
  • Revenue Next Year
  • RCUS $25.77
  • WEAV $15.39
  • P/E Ratio
  • RCUS N/A
  • WEAV N/A
  • Revenue Growth
  • RCUS N/A
  • WEAV 19.58
  • 52 Week Low
  • RCUS $6.50
  • WEAV $8.10
  • 52 Week High
  • RCUS $18.98
  • WEAV $17.63
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 48.63
  • WEAV 50.64
  • Support Level
  • RCUS $7.06
  • WEAV $9.06
  • Resistance Level
  • RCUS $9.35
  • WEAV $10.69
  • Average True Range (ATR)
  • RCUS 0.55
  • WEAV 0.49
  • MACD
  • RCUS 0.06
  • WEAV 0.13
  • Stochastic Oscillator
  • RCUS 53.28
  • WEAV 73.70

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

Share on Social Networks: